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Objective: Transcatheter aortic valves have been successfully implanted into the calcified leaflets of patients with
severe aortic stenosis. However, their stability in patients with noncalcified aortic insufficiency is unknown. Sim-
ilar to thoracic and abdominal aortic stent grafts, transcatheter aortic valves are subjected to antegrade ejection
forces during systole. However, retrograde migration forces into the left ventricle are also generated by the dia-
stolic pressure gradient across the closed valve. It has been suggested that leaflet calcification anchors the pros-
thesis, and measurements of migration forces should be considered before clinical trials in noncalcified aortic
insufficiency. The objective of this study was to use computational fluid dynamics simulations to quantify forces
that could potentially dislodge the prosthesis.
Methods: A computational fluid dynamics model was developed to simulate systolic flow through a geometric
mesh of the aortic root and transcatheter aortic valves. Hemodynamic measurements were made at discrete mo-
ments during ejection. Unsteady control volume analysis was used for calculations of force on the mesh.
Results: Results of the simulation indicate that a total force of 0.602 N acts on the transcatheter aortic valves dur-
ing systole, 99% of which is in the direction of axial flow. The largest contributor to force was the dynamic pres-
sure gradient through the transcatheter aortic valves. This antegrade force is approximately 10 times smaller than
the retrograde force (6.01 N) on the closed valve during diastole.
Conclusion: Our model simulated systolic flow through a transcatheter aortic valve and demonstrated migration
into the left ventricle to be of greater concern than antegrade ejection.E
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STranscatheter aortic valves (TAVs) represent a minimally
invasive treatment for degenerative aortic stenosis as an
alternative to open aortic valve replacement. In this proce-
dure, TAVs are implanted via a retrograde femoral arterial
or antegrade transapical approach. The results have proven
effective in relieving symptoms of aortic stenosis. However,
no attempt has been made to use TAV as treatment for aortic
insufficiency or other valvular disease not involving degen-
erative calcification of the cusps. Unlike traditional biopros-
theses, which are sutured to the annulus, stent valves are
not secured within the aorta. The forceful ejection of blood
during systole could lead to stent dislodgement and ante-
grade migration distally into the arch or descending thoracic
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abdominal aortic stent grafts during long-term follow-up
of abdominal aortic aneurysms.1 However, unlike abdomi-
nal stent grafts, TAVs are subjected to retrograde forces dur-
ing diastole because of the pressure gradient across the
closed valve. This force could lead to stent migration into
the left ventricle. To the authors’ knowledge, no computa-
tional simulations have modeled TAV hemodynamics.
This study seeks to use computational fluid dynamics
(CFD) to investigate flow, wall shear stress, and total force
acting on the device to assess TAV migration in noncalcific
aortic insufficiency.
MATERIALS AND METHODS
Transcatheter Aortic Valve Geometry and
Simulation
A 3-dimensional geometric model or mesh was generated, extending
from the aortic annulus to the proximal descending thoracic aorta. The re-
gion to be studied in the greatest detail, the aortic root, contains geometry
of the aortic sinuses developed from anatomic measurements available in
literature.2,3 The ascending aorta and arch are modeled as a simple curved
pipe, excluding the arterial branches. A second mesh was generated of the
TAV and merged with the aortic mesh at the annulus. Assumptions were
made about the geometry of the TAV for the sake of simplicity. The simu-
lation represents TAV implantation within an incompetent valve, as op-
posed to a calcified, stenotic valve, and the native leaflets are presumed to
have a negligible effect on flow. The TAV and annulus are circular and con-
tiguous, allowing no paravalvular leak into the left ventricle. Second, the
TAV mesh does not include the stainless steel or nitinol frame of the stent.
When fully opened, the cusps of the TAV are flush with the frame and takerdiovascular Surgery c Volume 138, Number 5 1227
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the shape of the stent housing (Figure 1, A). An open cylinder was used to
model this geometry; the cusps are not attached at the commissures and do
not intrude into the sinus cavity (Figure 1, B).
This study models approximately 300 msec of systolic flow. Although in
vivo, the opening of the TAV takes place over a finite time, the precise ki-
nematics of the opening and closing of the cusps during this period are not
simulated. As such, unsteady flow from the left ventricle is assumed to begin
after instantaneous TAV opening, ignoring flow during the short period
when the valve is partially opened. Throughout the simulation of systole
the cusps remain static and fully open, fixed within the stent. The loading
conditions driving flow through the mesh were taken from the literature
and are representative of normal systolic pressures.4 CFD simulations are
performed to study flows through the rigid mesh; aortic root dilation is
not modeled.
Computational Fluid Dynamics
The CFD methodology used in this study has previously proven its effi-
cacy characterizing flow in the aortic arch and bifurcations.4,5 This approach
requires a detailed 3-dimensional and time-dependent description of flow
through the aortic valve. The simulation is driven by a system of fluid
flow equations, Navier–Stokes, which for an incompressible fluid in dimen-
sionless control volume form are as follows:
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where p is the pressure, t is the viscous stress tensor, Re ¼ 2RU
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Þ1=2is theWomersley parameter, R is the inlet radius
of the aorta, Uis the maximum inlet velocity, n is the kinematic viscosity of
the fluid, andu is the inlet pulse frequency (u¼2pf where f is the heart rate).
Blood flowing through the aorta is modeled as a Newtonian fluid, appropri-
ate for CFD simulations of arterial flow.6 Computational evaluations are
made for discrete time intervals at a rate of 320 computational steps per sec-
ond. Values for the maximum velocity and flow area are used as reference to
nondimensionalize computations, allowing good estimation to be made
over a significant Reynolds number and size range. These values are as
follows:
Umax ¼ 60 cm=sec Aflow ¼ pr2 r ¼ 1:2 cm Aflow ¼ 4:52x104m2 (3)
The total force on the aortic valve is obtained by performing an unsteady
control volume force analysis, and the control volume is defined by the
mesh that surrounds the valve and the meshes across the inlet and exit areas
of the valve.7 There are 4 contributions to the force: (1) the fluid momentum
flux at the inlet and exit of the valve; (2) the unsteady change of momentum
in the valve control volume; (3) the dynamic pressure force on the valve; and
(4) the viscous shear stresses on the outer wall of the valve.
The dimensionless force coefficient, Cforce, is defined as follows:
Cforce ¼ Forcereal
rU2maxAflow
where rfluid density UmaxMaximum flow velocity (4)
The values of pressure and shear stress in the figures have also been made
dimensionless in the following manner:1228 The Journal of Thoracic and Cardiovascular Sup ¼ pdynamic
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RESULTS
Flow Through the Transcatheter Aortic Valve
The results of the simulation are presented first with
velocity vectors and dynamic pressure contours (Figure 2).
It should be mentioned that the dynamic pressure field is
not the blood pressure, but rather it is determined from the
local spatial gradient of the blood pressure caused by the
flow. Velocity fields in the aortic arch and at points distal
are essentially identical to those seen in unsteady flow anal-
ysis through a simple curved pipe, suggesting that implanta-
tion of the TAV has a negligible effect on hemodynamics
downstream of the ascending aorta.8 Control of flow in
the arch is dominated by the Womersley parameter, which
is sensitive to changes in heart rate, as opposed to the
geometry.
Unlike the flow seen in the aortic arch, the TAV alters he-
modynamics in the root and ascending aorta considerably
(Figure 3). Flow in the center of the aortic lumen continues
to converge and accelerate after the valve. However, average
velocity across the entire vessel decreases distal to the valve
because of the increase in lumen area. If the leaflets remain
fully open during ejection and the wall motion is neglected,
the net fluid that flows in and out of the sinus cavity must
be equal because of conservation of mass. Unsteady flow
into and out of the sinus region is due to non-uniform fluid
entrainment locally at the valve tip. The value of unitless
flow presented in the figure is the axial component of flow,
and the sinus bulge creates the movement of blood in both
the positive and negative direction, as well as rotational
flow around the leaflet. The geometric cause of the unsteady
sinus flows is the non-axisymmetric shape of the sinus cavity,
which influences the interaction with the flow in the valve.
Forces on the Transcatheter Aortic Valve
Throughout ejection, the largest component of force is
pressure (Figure 4), followed by momentum flux force.
Both the viscous force on the outside of the valve and un-
steady flow forces in the valve are less than a few percent
of the total force. Total force on the TAV is the magnitude
or absolute value of the components of force in all 3 dimen-
sions. However, approximately 99% of the total force is in
the direction of axial flow. Total force peaks during maxi-
mum systolic flow at 0.602 Newtons. The pressure field
observed corresponds with previous simulations and is dom-
inated by the unsteady frequency parameter, a, in the large
arteries.8,9rgery c November 2009
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Figure 5 shows the magnitude or absolute value of the
total wall shear stress on the ventricular TAV leaflet surfaces
and the sinus surface. Shear stress on the TAV is larger than
on the sinuses on average; however, at locations near the
valve tip the sinus wall shear stress can approach more
than 50% of valve wall shear stresses. At all times in the
simulation, the maximum shear stress on the aortic sinus
wall is located just distal to the bulge region of the sinus
FIGURE 1. TAV schematics. A, Schematic of an open TAV. B, Surface
mesh of the TAV within the aortic root. TAV, Transcatheter aortic valve.The Journal of Thoracic and Cawhere the diameter is greatest. It seems that dynamic fluid
entrainment caused by the sinus influences this profile of
wall shear stress.
The greatest shear stress on the TAV occurs near the tip of
the leaflets and peaks during maximum flow through the
valve, corresponding to previous studies of shear in both
the root and the aortic arch.4 Maximum shear stress on the
valve leaflet tips is approximately 40 Pa (Equation 5).
Diastolic Force: Engineering Estimates
Considerable antegrade force acts on the TAV during
ejection, pushing the prosthesis along the axis of flow. To
determine the significance of this force, the entire cardiac
cycle should be taken into consideration. At the beginning
FIGURE 2. Velocity vectors and dynamic pressure contours in the aortic
arch. A, Maximum flow acceleration. B, Maximum flow. C, Maximum
flow deceleration.rdiovascular Surgery c Volume 138, Number 5 1229
Evolving Technology/Basic Science Dwyer et al
E
T
/B
Sof diastole, a small retrograde flow occurs during valve
closure but likely generates negligible force. During left ven-
tricular relaxation, however, the closed TAV is subjected to
a large retrograde pressure gradient. A simple approximation
can be made to estimate the resulting force on the TAV using
left ventricular and ascending aortic pressure. The net pres-
sure force occurs along the axis of flow and depends only on
the projected area in that direction, as defined by the valve
radius rvalve at the annulus. Considering the same size
TAV used in the CFD simulation, area and force are:
rvalve ¼ 12 mm Aprojected ¼ pr2valve ¼ 4:52 cm2
Force ¼ DpvalveAprojected ¼ 6:01 N ¼ 1:36 lbf
Peak force during diastole is approximately an order of
magnitude greater than peak force during systole.
DISCUSSION
CFD simulations in this study characterize for the first time
flow though TAV and quantify the hemodynamics from the
annulus to the descending aorta. Jet flow through the TAV
leads to flow in the center of the lumen, converging distal
FIGURE 3. Velocity profile with velocity contours in the aortic root.
A, Maximum flow acceleration. B, Maximum flow. C, Maximum flow
deceleration.1230 The Journal of Thoracic and Cardiovascular Sto the valve. A peak force of 0.602 N is exerted on the
TAV, approximately 99% ofwhich is in the direction of axial
flow. The leaflet tips are subjected to a wall shear stress of
approximately 40 Pa. Finally, a simple engineering estimate
shows total force during diastole to be 6.01 N, approximately
10 times larger than force during ejection through the TAV.
Implantation of Transcatheter Aortic Valves
The first human percutaneous TAV implantation was per-
formed in 2002 by Alain Cribier and colleagues.10 Overall,
TAV has 73% to 100% implant success and procedural
mortality of 2% to 14% in patients with predicted surgical
mortalities of 12% to 31%. Surgical conversion was 0%
to 2%, periprocedural stroke occurred in 0% to 10%, and
30-day mortality was 12% to 22%.10-19 Hemodynamically
successful treatment of calcified aortic stenosis was achieved
without major complications. Valve area significantly im-
proved (0.5–0.7 to 1.5–1.7 cm2); transvalvular gradients
substantially decreased (32–46 mm Hg to 9–11 mm Hg);
and ejection fraction increased (45%–53% to 53%–
60%). However, TAV implantation has never been
attempted for treatment of aortic insufficiency in humans.
Structural differences between a calcified, stenotic aortic
valve and a dilated or prolapsing incompetent valve are sig-
nificant. Patients requiring ascending aortic replacement or
valve-sparing aortic root replacement to treat aortic insuffi-
ciency would not seem to be good candidates for TAV. Al-
though the proportion of patients with isolated aortic
insufficiency may not be substantial, once TAV technology
becomes Food and Drug Administration approved, off-label
use of TAV may potentially be expanded to patients without
FIGURE 4. Force on the TAV. Magnitude of total force and pressure, the
largest contributing component, during systole. Force and time are pre-
sented in dimensionless units from the simulation.urgery c November 2009
Dwyer et al Evolving Technology/Basic ScienceFIGURE 5. Contours of wall shear stress on the transcatheter aortic valve and aortic root. A, Maximum flow acceleration. B, Maximum flow. C, Maximum
flow deceleration.E
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use, computational and experimental studies should be con-
ducted to evaluate the safety of TAV under this pathology.
Predicting Stent Migration
Clinically, TAVs rarelymigrate when seated correctly, de-
spite large shear forces during systole and pressure gradients
during diastole. One hypothesis is that calcification of the na-
tive leaflets anchors the stent in place because of a reduction
in annular pliability.20 Should this hypothesis be true, treat-
ment of aortic insufficiencywith TAV is likely not advisable.
In Cribier’s early experience of percutaneous treatment for
severe aortic stenosis, 1 of the 6 enrolled patients died as a re-
sult of TAV migration.13 This patient had a highly irregular
valve, with 1 leaflet torn away from the annulus during pre-
TAV aortic balloon valvuloplasty, which resulted in massive
aortic insufficiency. Because of the anatomy, the TAV was
deployed but ejected distally during full balloon inflation,
which the investigators believe led to its migration because
of the absence of calcium for stent valve fixation.
Aortic stenosis cannot be readily re-created in an animal
model, and thus in vivo animal studies more accurately sim-
ulate aortic insufficiency than stenosis. During a 2006 study
of TAV implantation in pigs, 8 of 26 valves migrated (2 dis-
tal, 6 retrograde).21 Of these, 5 valves were cited to migrate
into the left ventricle after a normal implantation when theThe Journal of Thoracic and Capig was weaned from cardiopulmonary bypass or rapid ven-
tricular pacing. Another investigation of TAV deployment
within pigs reported that 40% of the prostheses migrated
shortly after being seated (6/15 total; 3 distal, 3 retrograde
migrations).20 The investigator cited the size and compli-
ance of the normal, noncalcified root as a possible explana-
tion for the dislodgement of the prosthesis. In light of these
experimental results, patients with pure aortic insufficiency
could present the same risk of migration, and additional
means should be taken to secure the stent.
Securing the Stent
Migration is a known complication of all stent grafts but
a clinical hazard and potential source of mortality for
TAVs. Mechanically, migration is a device failure created
when forces acting on the stent overcome the strength of
the stent’s attachment to the vessel wall. Studies using static
pressurization of abdominal aortic stent grafts within ca-
daver and animal models have been used to quantify the
force necessary for migration. Drag force, which holds the
stent in place, is highly dependent on the outer surface of
the device: 2 to 4 N for smooth stents and 7 to 12 N for stents
with hooks and barbs.22 Newer designs have drag forces
measured up to 25 N.23 When implanting a self-expanding
TAV in an animal model, both antegrade and retrograde mi-
grations were problematic.24 Initially, migration into the leftrdiovascular Surgery c Volume 138, Number 5 1231
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of retaining hooks to the design. In subsequent trials, the
stent migrated antegrade after a successful deployment. Re-
taining hooks were added to prevent early retrograde migra-
tion, and increasing the radial force of the stent wire and
oversizing the TAV were necessary to prevent migration
into the ascending aorta.
Study Limitations
The simulation results were generated using a simplified,
although physically reasonable, model of an implanted
TAV during systole. For the purpose of comparison, we
have made an engineering estimate of the closed TAV dur-
ing diastole. A comprehensive study, incorporating the sur-
face of the closed leaflets and the dynamic pressures in the
aorta and left ventricle, is necessary for a more accurate
prediction of diastolic force. As stated previously, this sim-
ulation does not model leaflet kinematics. The results show
that peak shear stress and total force on the TAV both occur
at maximum flow, indicating that the short period while
leaflets are still opening is unimportant for TAV failure.
The kinematics, however, are necessary to predict fatigue
and long-term degeneration resulting from leaflet bend-
ing.25 CFD simulation can calculate shear stress on TAV
leaflets in detail that would be extremely difficult or im-
possible to determine experimentally. Nonetheless, future
experimental and clinical investigation are necessary to
validate the results. Last, the compliance of the aortic
root and TAV is not incorporated in the model. We demon-
strate that as blood exits the left ventricle during systole, it
interacts with the distal edge of the TAV, and fluid entrain-
ment creates complex vortical flow in the sinus cavity.
Blood leaving the sinus along the aortic face of the TAV
leaflet pulls new blood into the sinus from near the aortic
root wall, creating regions of both positive and negative
axial flow. Eddy currents and turbulence may be created
in this region by interaction of the fluid at the boundaries
of the TAV and the compliant aortic root. Realistic simula-
tion of these complex phenomena requires the addition of
fluid–structure interaction to the model, which may be per-
formed in future studies.
CONCLUSIONS
CFD simulations in this study provide the first of its kind
data quantifying hemodynamics of TAVwithin an incompe-
tent aortic valve. The proposed treatment has not been at-
tempted clinically and has shown only limited success in
animals. Total force, likely the most significant result of
this study, indicates that antegrade migration of TAV may
not be a concern because it is in abdominal aortic stent grafts,
when compared with retrograde migration. However, the
drag force acting to prevent migration is unknown and pos-
sibly dependent on the direction of migration because of the
irregular geometry.1232 The Journal of Thoracic and Cardiovascular SuOverall, CFD models are useful to investigate how
a change in geometry leads to a change in hemodynamics.
If the change is significant, a complete fluid–structure inter-
action model should be developed to investigate the
deformation of the aortic root as well, and ultimately to
estimate the drag force necessary to prevent stent migration.
The TAV–root surface interaction will be the dominating
parameter of drag, and a reliable model for testing specific
surface geometries of both has 2 benefits. First, future
TAV designs could be developed with anchoring elements,
such as the hooks and barbs of abdominal aortic stents, to in-
crease drag. Second, patients with certain valve disease,
such as noncalcified incompetent leaflets, could be screened
to predict whether TAV implantation is safe. These 2 bene-
fits may lead to greater surgical success or an inclusion of
patients not currently considered for TAV.
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